These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 26725025

  • 1. Synthesis and positive inotropic activity evaluation of liguzinediol metabolites.
    Zhu HH, Chen YQ, Cheng D, Li W, Wang TL, Wen HM, Chen L, Liu J.
    Bioorg Med Chem Lett; 2016 Feb 01; 26(3):882-884. PubMed ID: 26725025
    [Abstract] [Full Text] [Related]

  • 2. Scaffold evaluation of liguzinediol analogs as novel cardiotonic agents.
    Liu Z, Li W, Qin K, Wen K, Zhu CJ, Li NG, Bian HM, Wen HM, Chen L.
    Pharmazie; 2013 Dec 01; 68(12):926-32. PubMed ID: 24400437
    [Abstract] [Full Text] [Related]

  • 3. Liguzinediol Enhances the Inotropic Effect of Rat Hearts via Inhibition of Protein Phosphatase (PP1 and PP2A) Activities.
    Li S, Huang H, Zhang M, Wang W, Xue S, Gao Y, Xie M, Chen K, Liu F, Chen L.
    J Cardiovasc Pharmacol; 2017 Apr 01; 69(4):236-244. PubMed ID: 28134629
    [Abstract] [Full Text] [Related]

  • 4. Liguzinediol protects against cardiac fibrosis in rats in vivo and in vitro.
    Wu X, Qi X, Lu Y, Lin C, Yuan Y, Zhu Q, Yin Q, Li W, Li Y, Bian H.
    Biomed Pharmacother; 2016 May 01; 80():260-267. PubMed ID: 27133065
    [Abstract] [Full Text] [Related]

  • 5. Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure.
    Li Y, Song P, Zhu Q, Yin QY, Ji JW, Li W, Bian HM.
    Acta Pharmacol Sin; 2014 Oct 01; 35(10):1257-64. PubMed ID: 25220638
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of liguzinediol mono- and dual ester prodrugs as promising inotropic agents.
    Zhang J, Li W, Wen HM, Zhu HH, Wang TL, Cheng D, Yang KD, Chen YQ.
    Molecules; 2014 Nov 05; 19(11):18057-72. PubMed ID: 25379643
    [Abstract] [Full Text] [Related]

  • 7. Zebrafish as a new model for phenotype-based screening of positive inotropic agents.
    Tang C, Xie D, Feng B.
    Chem Biol Drug Des; 2015 Mar 05; 85(3):253-8. PubMed ID: 24990095
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, biological evaluation, and pharmacokinetic study of novel liguzinediol prodrugs.
    Liu Z, Li W, Wen HM, Bian HM, Zhang J, Chen L, Chen L, Yang KD.
    Molecules; 2013 Apr 18; 18(4):4561-72. PubMed ID: 23599014
    [Abstract] [Full Text] [Related]

  • 9. Sulfotransferase-catalyzed biotransformation of liguzinediol and comparison of its metabolism in different species using UFLC-QTOF-MS.
    Shen F, Wen HM, Shan CX, Kang A, Dong B, Chai C, Zhang JY, Zhang Q, Li W.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul 01; 1089():1-7. PubMed ID: 29738966
    [Abstract] [Full Text] [Related]

  • 10. Identification of liguzinediol metabolites in rats by ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Shan CX, Li W, Wen HM, Wang XZ, Zhu YH, Cui XB.
    J Pharm Biomed Anal; 2012 Mar 25; 62():187-90. PubMed ID: 22277354
    [Abstract] [Full Text] [Related]

  • 11. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E, Michaels DC, Felice EL.
    Arch Inst Cardiol Mex; 1979 Mar 25; 49(5):892-907. PubMed ID: 398199
    [No Abstract] [Full Text] [Related]

  • 12. Metabolite identification of liguzinediol in dogs by ultra-flow liquid chromatography/tandem mass spectrometry.
    Shan CX, Li W, Wen HM, Wang XZ, Zhu XW, Cui XB.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep 15; 967():63-8. PubMed ID: 25078861
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure.
    Sabbah HN, Imai M, Cowart D, Amato A, Carminati P, Gheorghiade M.
    Am J Cardiol; 2007 Jan 22; 99(2A):41A-46A. PubMed ID: 17239704
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and pharmacological characterization of some benzazepinone derivatives.
    Budriesi R, Rampa A, Bisi A, Fabbri G, Chiarini A, Valenti P.
    Arzneimittelforschung; 1995 Mar 22; 45(3):234-9. PubMed ID: 7741775
    [Abstract] [Full Text] [Related]

  • 15. 4-Aroyl-1,3-dihydro-2H-imidazol-2-ones: a new class of cardiotonic agents. 2. Effect of 4-pyridoyl substituents and related compounds.
    Schnettler RA, Dage RC, Palopoli FP.
    J Med Chem; 1986 May 22; 29(5):860-2. PubMed ID: 3701794
    [Abstract] [Full Text] [Related]

  • 16. N-aralkyl substitution of 2-aminoindans. Synthesis and their inotropic and chronotropic activity in isolated guinea pig atria.
    Pérez JA, Domínguez JN, Angel JE, Duerto de Pérez Z, Salazar-Bookaman MM, Acosta H, Charris JE.
    Arzneimittelforschung; 1997 Nov 22; 47(11):1208-10. PubMed ID: 9428975
    [Abstract] [Full Text] [Related]

  • 17. Imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyrazines: the role of nitrogen position in inotropic activity.
    Spitzer WA, Victor F, Pollock GD, Hayes JS.
    J Med Chem; 1988 Aug 22; 31(8):1590-5. PubMed ID: 3397997
    [Abstract] [Full Text] [Related]

  • 18. [Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines].
    Hagen V, Hagen A, Heer S, Mitzner R, Niedrich H.
    Pharmazie; 1989 Jan 22; 44(1):20-3. PubMed ID: 2727022
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and positive inotropic activity of several 5-aminopyrido[2,3-d]pyrimidines. Part 5: Compounds with positive inotropic activity.
    Heber D, Ravens U, Schulze T.
    Pharmazie; 1993 Jul 22; 48(7):509-13. PubMed ID: 8415847
    [Abstract] [Full Text] [Related]

  • 20. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E, Schwinger R, Böhm M.
    J Cardiovasc Pharmacol; 1990 Jul 22; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.